Arantza Muriana

Biobide is attending SOT 60th Annual Meeting this year!

Biobide is attending SOT 60th Annual Meeting this year! Despite the event is being held virtually, Biobide did not want to miss this great event.

We will be presenting two posters:

  • "Developmental and Functional Kidney Toxicity Assay in Zebrafish Embryos"  on March 17th  from 11:15 a.m. to 1:00 p.m. (EST). 

  • "Validation of Zebrafish Embryotoxicity Test (ZET) as a Qualified Alternative Assay for Its Regulatory Use" on 23rd from 11:15 a.m. to 1:00 p.m. (EST).

Besides, Arantza Muriana, co-founder and R&D Director of Biobide will present and co-chair with Mamta Behl from NTP/NIEHS the Workshop Session  "The Need for Protocol Harmonization in the Advancement of Zebrafish as a Model for Toxicological Screening: Global Perspectives and Recent Advancements" on the 18th of March from 11:15 am to 2:00 pm (EST).

read more

Biobide presents a collaboration project with NIH-NIEHS at the American College of Toxicology Meeting in Florida

The American College of Toxicology is an international body of research and regulatory scientists dedicated to a safer global community, gathering large numbers of scientists from United States and other countries every year. The program of this year’s meeting was designed to provide excellent quality scientific content that is applicable to the practice of toxicology.

read more

Biobide, in collaboration with TECNUN (University of Navarra), present a poster at 58th Teratology Society Meeting in Clearwater, Florida, USA

Teratology Society Meeting (TSM) is an annual event that gathers a large number of academic, industrial and governmental scientists from various fields such as toxicology, developmental biology, reproduction and endocrinology, genetics, various clinical disciplines and many more. This year’s Teratology Society Meeting’s theme was “Mechanisms, Models, Mothers and Babies: Bringing Birth Defects Research into Practice” which included more than 12 scientific sessions on various related topics.

read more

Biobide’s presentation in World Preclinical Congress’ conference Predicting Drug Toxicity

World Preclinical Congress (WPC) is an annual event that focuses on newest trends and frontline technologies in drug discovery and translational research. This year, 17th WPC in Boston, USA, has brought more than 300 speakers and 1100 international delegates together, offering a unique opportunity to share knowledge and opinions in 18 conferences of different areas of research and development.

 

read more

Biobide’s team presents zebrafish as alternative model for cancer research in BIO2018

BIO International Convention is the largest global event for biotechnology industry organized by Biotechnology Innovation Organization, representing biotechnology companies, academic institutions, biotechnology centers and related organizations in the United States and in more than 30 other countries. More than 18,000 attendees gathered to this year’s conference in Boston, MA, USA, where cutting-edge innovations in the industry were presented by leading companies and clusters from 67 countries.

read more